Status:
COMPLETED
Observational Study of Approaches to Lipid-Lowering Therapy in Russian Patients With Coronary Heart Disease <<Treat to Goal>> (Study P05464)
Lead Sponsor:
Organon and Co
Conditions:
Coronary Heart Disease
Hypercholesterolemia
Eligibility:
All Genders
18-75 years
Brief Summary
This study is being performed to evaluate what variants of lipid-lowering therapy are used in Russian clinical practice in coronary heart disease (CHD) patients with hypercholesterolemia in whom the i...
Detailed Description
Given the observational nature of this study and that the assessment of a specific hypothesis is not foreseen, statistical assumption is not planned and the sample size calculation was not performed. ...
Eligibility Criteria
Inclusion
- Male and Female, from 18 to 75 years old;
- Established diagnosis of CHD;
- Previous (at least, within 1 month before inclusion in the present study) treatment with statin;
- Levels of plasma TC and LDL-C above the recommended target values
- (TC\> 4.5 mmol\\L; LDL-C\> 2.5 mmol/L);
- The written informed consent signed prior to the start of participation in the study.
Exclusion
- Contraindications for statin and ezetimibe (Ezetrol) administration in accordance with local Russian Federation medical instructions.
- Patients refused to participate in the study and/or did not sign informed consent form.
Key Trial Info
Start Date :
January 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2009
Estimated Enrollment :
712 Patients enrolled
Trial Details
Trial ID
NCT00730132
Start Date
January 1 2008
End Date
August 1 2009
Last Update
February 9 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.